- ISIN
- US2546041011
- WKN
- A3D063
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Aug 12, 2020
Highlights
- Market Cap
- $2.73B
- Enterprise Value
- $2.67B
- EPS (TTM)
- -$6.71
- Gross Profit (TTM)
- -$265.00K
- EBITDA (TTM)
- -$243.47M
- Year Range
- $40.00 - $99.50
- Target Price
- $104.14
- ROA (TTM)
- -32.20%
- ROE (TTM)
- -35.09%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IRON Performance Chart
Disc Medicine Inc. (IRON) is down 10.8% since the beginning of the year. At $71 per share, IRON is trading 28.8% below its 52-week high of $100. Investors who bought $1,000 worth of IRON shares 5 years ago would now be looking at an investment worth $1,058.
Loading charts...
Returns By Period
Disc Medicine Inc. (IRON) has returned -10.84% so far this year and 37.18% over the past 12 months.
Disc Medicine Inc.
- 1D
- 0.01%
- 1M
- 5.96%
- YTD
- -10.84%
- 6M
- -10.99%
- 1Y
- 37.18%
- 3Y*
- 10.50%
- 5Y*
- 1.14%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
IRON Monthly Returns History
Based on dividend-adjusted daily data since Aug 12, 2020, IRON's average daily return is +0.07%, while the average monthly return is +1.38%. At this rate, an investment would double in approximately 4.2 years.
Historically, 56% of months were positive and 44% were negative. The best month was Apr 2023 with a return of +54.5%, while the worst month was Apr 2024 at -55.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, IRON closed higher 49% of trading days. The best single day was Dec 30, 2022 with a return of +47.3%, while the worst single day was Apr 1, 2024 at -45.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.63% | -13.84% | -4.02% | 3.14% | 5.49% | 1.77% | -10.84% | ||||||
| 2025 | -11.99% | 0.68% | -11.64% | -0.44% | -5.54% | 13.45% | 12.84% | -0.19% | 10.79% | 30.48% | 8.28% | -14.94% | 25.25% |
| 2024 | 13.83% | 4.44% | -9.33% | -55.28% | 21.95% | 32.75% | -4.24% | 17.75% | -3.31% | -8.79% | 41.57% | -0.08% | 9.76% |
| 2023 | 10.61% | 13.64% | -15.24% | 54.46% | 13.44% | 19.58% | 11.71% | 6.75% | -11.27% | -2.49% | 20.45% | 4.68% | 190.40% |
| 2022 | -32.65% | -30.61% | 2.21% | 8.63% | -15.23% | 32.03% | -9.47% | 1.31% | 5.81% | 9.76% | -4.44% | 15.64% | -31.65% |
| 2021 | 7.27% | 28.81% | -10.86% | -13.73% | 5.22% | -47.40% | -37.09% | 20.88% | -17.89% | -5.94% | -27.37% | 5.43% | -73.55% |
Benchmark Metrics
Disc Medicine Inc. has an annualized alpha of 5.27%, beta of 0.85, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since August 12, 2020.
- This stock participated in 170.66% of S&P 500 Index downside but only 92.95% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 5.27%
- Beta
- 0.85
- R²
- 0.04
- Upside Capture
- 92.95%
- Downside Capture
- 170.66%
Return for Risk
Risk / Return Rank
IRON ranks 63 for risk / return — better than 63% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Disc Medicine Inc. (IRON) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IRON | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.33 | ||
| Sortino ratioReturn per unit of downside risk | -1.48 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.37 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.92 | 2.78 | -1.86 |
| Martin ratioReturn relative to average drawdown | 1.96 | 12.44 | -10.48 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Disc Medicine Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Disc Medicine Inc. was 93.22%, occurring on May 26, 2022. The portfolio has not yet recovered.
The current Disc Medicine Inc. drawdown is 60.67%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -93.22%May 2022 | 1y 2mo | — | 5y 3moMar 2021 - now |
2021 correction2021 | -15.99%Mar 2021 | 5d | 3d | 8dMar 2021 - Mar 2021 |
2020 correction2020 | -14.70%Nov 2020 | 1mo 13d | 1mo 29d | 3mo 12dSep 2020 - Jan 2021 |
2021 correction2021 | -10.52%Jan 2021 | 13d | 5d | 18dJan 2021 - Feb 2021 |
2021 correction2021 | -10.37%Feb 2021 | 4d | 14d | 18dFeb 2021 - Feb 2021 |
Drawdown Indicators
| IRON | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.22% | -56.78% | -36.44% |
Max Drawdown (1Y)Largest decline over 1 year | -40.55% | -9.10% | -31.45% |
Max Drawdown (3Y)Largest decline over 3 years | -64.79% | -18.90% | -45.89% |
Max Drawdown (5Y)Largest decline over 5 years | -81.46% | -25.43% | -56.03% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -60.67% | -1.80% | -58.87% |
Average DrawdownAverage peak-to-trough decline | -66.40% | -10.71% | -55.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.07% | 2.03% | +17.04% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Disc Medicine Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Disc Medicine Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IRON in comparison with other companies in the Biotechnology industry. Currently, IRON has a P/B value of 4.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IRON
Add Disc Medicine Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IRON